Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

First patient scanned in new cancer imaging technique

October 6, 2022
admin
The first cancer patient in Europe has been scanned with a revolutionary imaging technique that could enable doctors to see whether a drug is working within a day or two of starting treatment.

FDA clears metformin for patients with impaired kidney function

October 6, 2022
admin
America's Food and Drug Administration has given the OK for diabetes drugs that contain metformin to be used by some patients with impaired kidney function.

App launched to monitor diabetes levels

October 6, 2022
admin
A new app has been launched that allows user to monitor their blood sugar levels through their smartphone.

New treatment for hypercholesterolaemia available in the UK

October 6, 2022
admin
A new treatment for hypercholesterolaemia is now available in the UK for some patients.

New research data reveals SaxendaR offers ‘significant improvements’ in cardiometabolic risk factors

October 6, 2022
admin
Data taken from a long-running clinical trial has revealed that when combined with increased physical activity and a reduced-calorie diet, SaxendaR (liraglutide 3mg) offers significant improvements in cardiometabolic risk factors compared to placebo.

New schizophrenia treatment could soon be available in EU

October 6, 2022
admin
A new drug for the treatment of schizophrenia could soon be available in the European Union after the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending marketing authorisation for Trevicta (paliperidone palmitate, a 3-monthly injection).

Is there a link between oral health and the rate of cognitive decline?

October 6, 2022
admin
Better oral hygiene and regular dental visits may play a role in slowing cognitive decline as people age, although evidence is not definitive enough to suggest that one causes the other. 

New data for liraglutide in type 2 diabetes

October 6, 2022
admin
Findings from a clinical trial comparing  liraglutide 1.8mg (Victoza) and sitagliptin (100mg), both in combination with metformin, demonstrated that switching from sitagliptin to liraglutide provided superior HbA1c reductions versus continuing with sitagliptin treatment in adults with type 2 diabetes.  

European Medicines Agency recommends seven new medicines

April 24, 2024
Rob Mair
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended seven new medicines at its March meeting, it has been announced.

Clinical trial supports liraglutide compared to sitagliptin in treatment of type 2 diabetes

October 6, 2022
admin
Findings from a clinical trial comparing Victoza (liraglutide 1.8 mg) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin to liraglutide provided superior HbA1c reductions compared to continuing with sitagliptin treatment in adults with type 2 diabetes.

Rare dementias research receives funding boost

October 6, 2022
admin
Researchers at the University College London will soon be able to investigate a number of rare dementias, thanks to a funding boost from Alzheimer's Research UK, it has been announced.

Lesbian, gay or bisexual individuals twice as likely to experience mental health issues, research finds

October 6, 2022
admin
Adults who identify as lesbian, gay or bisexual (LGB) are twice as likely as their heterosexual counterparts to experience anxiety or depression, according to research.

New PHE data on salt consumption levels

October 6, 2022
admin
Adults have cut their average salt consumption by 0.9 grams per day in the decade from 2005 to 2014 according to new data from Public Health England's National Diet and Nutrition Survey. 

Bladder cancer and the general practitioner

October 6, 2022
admin
Bladder cancer is a common cause of cancer-related death. With improved survival linked to early diagnosis, GPs need to be aware of signs and symptoms

Depression: Treatment and management in primary care

April 11, 2024
admin
In the second part of his review, Professor Safiullah Afghan looks at how to manage depression in a primary care setting

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy